Positron Emission Tomography Market Overview
According to Kings Research, the global positron emission tomography (PET) market is witnessing steady growth as healthcare providers increasingly adopt advanced medical imaging technologies for the diagnosis, staging, and monitoring of cancer, neurological disorders, cardiovascular diseases, and other complex medical conditions. Rising healthcare expenditure, increasing prevalence of chronic diseases, advancements in molecular imaging, and the growing integration of PET with computed tomography (CT) and magnetic resonance imaging (MRI) are supporting the expansion of the market. The global positron emission tomography market size was valued at USD 1,090.7 million in 2024 and is projected to grow from USD 1,130.0 million in 2025 to USD 1,447.4 million by 2032, exhibiting a CAGR of 3.61% during the forecast period.
Get the Full Detailed Insights Report: https://www.kingsresearch.com/report/positron-emission-tomography-market-3035
Positron emission tomography is an advanced functional imaging technology that enables healthcare professionals to visualize metabolic and biochemical activity within tissues and organs. Unlike conventional imaging techniques that primarily provide anatomical information, PET can provide insights into physiological processes by using radioactive tracers that accumulate in specific tissues.
The growing adoption of personalized medicine is further increasing the importance of molecular imaging technologies. PET can help clinicians identify disease characteristics, evaluate treatment response, and support more informed therapeutic decisions. As healthcare systems increasingly emphasize early diagnosis and precision treatment, demand for PET imaging solutions is expected to increase throughout the forecast period.
Increasing Prevalence of Cancer Drives PET Adoption
The rising global burden of cancer is one of the major factors supporting the positron emission tomography market. PET imaging plays an important role in oncology by helping physicians identify abnormal metabolic activity, determine disease extent, detect metastasis, and assess treatment response.
PET/CT has become particularly valuable in cancer management because it combines functional information from PET with anatomical information from CT. This combination enables physicians to obtain more comprehensive information during a single examination.
The increasing focus on early cancer detection and personalized treatment strategies is encouraging healthcare facilities to invest in advanced diagnostic imaging technologies. PET-based imaging can also support treatment planning and follow-up examinations, creating demand across different stages of cancer care.
As oncology centers, hospitals, and diagnostic imaging facilities expand their capabilities, the demand for PET scanners and radiotracers is expected to increase.
Growing Use in Neurological and Cardiovascular Applications
Beyond oncology, PET is increasingly used in neurological and cardiovascular applications. Neurological PET imaging can provide information about brain metabolism and biological processes associated with various neurological disorders.
Growing research into neurodegenerative diseases and brain disorders is increasing interest in advanced functional imaging. PET can help researchers and clinicians study disease mechanisms and evaluate changes in brain activity.
In cardiovascular care, PET imaging can be used to evaluate myocardial perfusion and metabolic activity. The technology can support the assessment of cardiac function and help healthcare professionals make diagnostic and treatment decisions.
The expansion of these applications is expected to diversify demand for PET technology beyond cancer diagnosis and monitoring.
Technological Advancements Strengthen Market Development
Technological innovation remains an important factor shaping the PET market. Manufacturers are developing scanners with improved image quality, higher sensitivity, faster acquisition, and enhanced patient comfort.
Modern PET systems are increasingly designed to improve workflow efficiency while reducing scanning time and, in selected applications, optimizing radiation exposure. These improvements can make PET imaging more practical for hospitals and diagnostic centers with high patient volumes.
The development of advanced detector technologies is also supporting improvements in PET imaging performance. Better detector sensitivity and improved image reconstruction techniques can contribute to clearer and more detailed images.
Artificial intelligence is another emerging area of interest. AI-based technologies can assist with image reconstruction, image analysis, workflow optimization, and interpretation support. Continued advances in AI and medical imaging software are expected to create additional opportunities for PET manufacturers and healthcare providers.
PET/CT Remains a Major Modality
Based on modality, the positron emission tomography market is segmented into stand-alone PET, PET/CT, and PET/MRI.
PET/CT has become a widely adopted imaging modality because it combines the functional information of PET with the anatomical detail provided by CT. This combination can improve disease localization and provide comprehensive diagnostic information.
The technology is particularly valuable in oncology, where accurate localization and staging of tumors are essential for treatment planning. PET/CT can also support monitoring of treatment response and identification of recurrent disease.
The widespread installation of PET/CT systems in hospitals, cancer centers, and diagnostic imaging facilities is expected to support the growth of this segment.
PET/MRI Offers Advanced Imaging Capabilities
PET/MRI represents an advanced hybrid imaging technology that combines molecular imaging with the superior soft-tissue contrast of MRI.
The modality is particularly attractive for applications involving the brain, head and neck, pediatric imaging, and selected oncology applications. PET/MRI can provide complementary functional and anatomical information while potentially reducing radiation exposure compared with PET/CT in certain clinical scenarios.
Although PET/MRI adoption remains more limited than PET/CT due to higher system complexity and investment requirements, ongoing technological improvements and increasing demand for advanced imaging are expected to create opportunities for the segment.
Research institutions and specialized medical centers are likely to remain important adopters of PET/MRI technology.
Full-Ring PET Scanners Provide High-Quality Imaging
Based on product type, the market is categorized into full-ring PET scanners and partial-ring PET scanners.
Full-ring PET scanners incorporate detectors around the patient’s body to capture a large amount of emitted radiation and generate detailed functional images. These systems are widely used in advanced diagnostic imaging applications.
Full-ring configurations can offer high sensitivity and improved image quality, making them suitable for oncology, neurological, and cardiovascular examinations. Increasing demand for accurate functional imaging is expected to support the adoption of advanced full-ring PET systems.
Healthcare providers are also increasingly focused on equipment productivity and patient throughput. Improvements in scanner design and software can help imaging facilities optimize workflow and accommodate growing patient demand.
Role of Radiotracers and Isotopes
Radiotracers and isotopes represent a critical component of PET imaging. These radioactive substances are designed to target specific biological processes and enable visualization of metabolic activity.
Fluorine-18-based tracers are widely used in PET imaging, particularly in oncology. Other isotopes and specialized radiotracers are also used for neurological, cardiovascular, and research applications.
The increasing development of disease-specific radiotracers is expanding the clinical capabilities of PET imaging. New tracer development can provide physicians with more detailed information about biological processes and disease characteristics.
However, the availability, production, transportation, and short half-life of certain radiotracers can create logistical challenges. Healthcare facilities require reliable radiopharmaceutical supply chains to maintain consistent PET imaging services.
Investment in radiopharmaceutical production infrastructure and improvements in distribution networks are therefore expected to remain important for market development.
Hospitals and Diagnostic Centers Drive End-User Demand
PET systems are primarily used across hospitals, diagnostic imaging centers, specialty clinics, research institutions, and other healthcare facilities.
Hospitals represent a major end-user segment because they provide comprehensive oncology, cardiology, neurology, and other specialty services. The availability of advanced imaging technologies can improve diagnostic capabilities and support multidisciplinary patient care.
Cancer centers are particularly important users of PET systems due to the technology’s role in cancer staging, treatment planning, and monitoring.
Diagnostic imaging centers are also expanding their advanced imaging capabilities to meet increasing demand for specialized diagnostic services. As healthcare providers move toward early detection and personalized care, diagnostic facilities are expected to invest in modern PET systems and related technologies.
Research institutions are another important end user. PET plays a significant role in pharmaceutical research, neuroscience, drug development, and clinical trials.
Increasing Healthcare Investment Supports Market Growth
Growing healthcare expenditure across developed and emerging economies is creating opportunities for advanced diagnostic imaging technologies.
Healthcare providers are investing in modern imaging infrastructure to improve diagnostic accuracy and patient outcomes. Government initiatives aimed at strengthening healthcare infrastructure can also support the adoption of sophisticated imaging systems.
In emerging economies, increasing access to specialized healthcare services and the expansion of private hospitals are contributing to demand for advanced diagnostic equipment.
However, the high initial cost of PET systems, ongoing maintenance requirements, radiotracer availability, and the need for trained professionals can limit adoption, particularly in resource-constrained healthcare systems.
Manufacturers are therefore focusing on developing more efficient and cost-effective imaging systems while improving workflow and operational performance.
Regional Analysis
The positron emission tomography market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America
North America is expected to remain an important market for positron emission tomography due to advanced healthcare infrastructure, high adoption of medical imaging technologies, and significant healthcare expenditure.
The region has a strong presence of hospitals, cancer treatment centers, research institutions, and diagnostic imaging facilities. High awareness of advanced diagnostic technologies and increasing demand for precision medicine are supporting PET adoption.
The development of new radiotracers and increasing integration of advanced software and AI technologies are expected to create further opportunities in the region.
Europe
Europe represents another significant market due to its established healthcare infrastructure and growing emphasis on early disease diagnosis.
The increasing prevalence of cancer and neurological diseases is supporting demand for advanced functional imaging. Healthcare providers are also investing in hybrid imaging technologies to improve diagnostic capabilities.
Research activities involving molecular imaging and radiopharmaceutical development are expected to support long-term market growth across major European economies.
Asia Pacific
Asia Pacific is expected to offer significant growth opportunities due to expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness of advanced diagnostic technologies.
Countries such as China, Japan, India, and South Korea are increasing investments in medical imaging infrastructure. The expansion of cancer treatment centers and specialty hospitals is expected to support demand for PET systems.
The region also presents opportunities for manufacturers as healthcare providers seek to improve access to advanced diagnostic services.
Latin America
Latin America is expected to witness gradual market growth as healthcare infrastructure develops and access to advanced diagnostic technologies improves.
The increasing prevalence of chronic diseases and expansion of private healthcare facilities are contributing to demand for advanced imaging systems.
Brazil and Mexico represent important markets due to their relatively developed healthcare infrastructure and growing investment in specialized medical services.
Middle East & Africa
The Middle East & Africa region presents emerging opportunities for PET imaging due to increasing healthcare investments and the development of specialized medical centers.
Governments and private healthcare organizations are increasingly investing in modern healthcare infrastructure. The expansion of oncology services and specialized diagnostic facilities is expected to support the adoption of PET technology.
Competitive Landscape
The global positron emission tomography market is characterized by competition among established medical imaging companies, radiopharmaceutical providers, and specialized technology developers.
Market participants are focusing on technological innovation, strategic collaborations, product launches, and expansion of healthcare solutions to strengthen their market positions.
Companies are developing PET systems with improved sensitivity, faster scanning capabilities, enhanced image reconstruction, and better workflow integration. Hybrid imaging solutions such as PET/CT and PET/MRI remain important areas of technological development.
The radiopharmaceutical segment is also becoming increasingly important as healthcare providers require reliable access to tracers for PET examinations. Partnerships between imaging equipment manufacturers, pharmaceutical companies, radiopharmaceutical developers, and healthcare institutions can help expand clinical applications.
Future Outlook
The global positron emission tomography market is expected to maintain steady growth through 2032. The market is projected to increase from USD 1,130.0 million in 2025 to USD 1,447.4 million by 2032, registering a CAGR of 3.61% during the forecast period.
The increasing burden of cancer and other chronic diseases will remain a key factor supporting demand for advanced imaging. PET’s ability to provide functional and metabolic information gives it an important role in modern diagnostic and therapeutic workflows.
Hybrid imaging is expected to remain a major area of growth. PET/CT is likely to maintain its strong position due to its established clinical applications, while PET/MRI may gain opportunities as technology becomes more accessible and clinical applications expand.
Advancements in radiotracers, AI-powered imaging software, detector technologies, and image reconstruction are also expected to improve PET’s clinical utility.
The expansion of healthcare infrastructure in emerging markets represents another major opportunity. As hospitals and diagnostic centers in developing economies increase their investment in advanced imaging, PET adoption is expected to gradually expand.
Conclusion
The global positron emission tomography market is positioned for steady expansion, supported by increasing demand for advanced diagnostic imaging, rising prevalence of cancer and chronic diseases, technological advancements, and growing adoption of personalized medicine.
With the market projected to reach USD 1,447.4 million by 2032, PET technology is expected to remain an important component of modern medical imaging. PET/CT will continue to play a major role in oncology and other clinical applications, while PET/MRI and advanced radiotracer technologies offer opportunities for further innovation.
The increasing integration of artificial intelligence, improved scanner performance, development of specialized radiotracers, and expansion of healthcare infrastructure are expected to shape the industry’s future. As healthcare providers continue to prioritize earlier diagnosis and more precise treatment decisions, demand for PET-based imaging solutions is likely to remain resilient throughout the forecast period.
